Company / Free Cash Flow per Share
Bio-Techne Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$1.62
FY2025
5-year range
$1.50 / $4.06
FY2021-FY2025
Trend
+8.3%
vs FY2024
Sector context
#80 of 148
Health Care
What the data says
At $1.62, Bio-Techne's free cash flow per share ranks #80 of 148 in the Health Care sector. Free Cash Flow per Share returned to growth in FY2025 after 3 years of decline, reaching $1.62.
Based on SEC 10-K filings.
1.62 in FY2025 with a 5-year CAGR of -16.7%.
Declined from $1.97 to $1.62 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -25.6%
- 5-Year CAGR
- -16.7%
- 10-Year CAGR
- -
Sector benchmark
#80 of 148 in Health CareTop 54% of 148This company $1.62 Sector average $5.05
▼
-67.9% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 8.3% year-over-year.
- Ranks #80 out of 148 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2019.
- Lowest free cash flow per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.62 | +8.3% |
| FY2024 | $1.50 | -23.8% |
| FY2023 | $1.97 | -50.1% |
| FY2022 | $3.94 | -3.0% |
| FY2021 | $4.06 | +0.4% |
| FY2020 | $4.05 | -2.6% |
| FY2019 | $4.15 | +5.8% |
| FY2018 | $3.93 | +13.8% |
| FY2017 | $3.45 | +0.7% |
| FY2016 | $3.43 | +6.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026